Related Articles
Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes
Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
Quantitative volumetric assessment of the solid portion percentage on CT images to predict ROS1/ALK rearrangements in lung adenocarcinomas
CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report